Status:
COMPLETED
Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling
Lead Sponsor:
Vienna Institute for Research in Ocular Surgery
Conditions:
Macular Edema, Cystoid
Eligibility:
All Genders
18+ years
Brief Summary
Aim of the study is to assess the rate of postoperative intraretinal cystoid changes after pars plana vitrectomy with membrane peeling and peribulbar application of triamcinolone acetonide and to exam...
Detailed Description
Epiretinal membranes (ERM) are disorders leading to vision loss and metamorphopsia. Vitrectomy with membrane peeling has developed to be the gold-standard in treatment of ERM. Nevertheless, there are ...
Eligibility Criteria
Inclusion
- presence of an ERM
- indication for membrane peeling defined as significant loss of vision and/or metamorphopsia due to the ERM
- application of periocular triamcinolone acetonide at the end of surgery
- at least one follow-up examination present in the patient's history
Exclusion
- macular edema caused by conditions other than ERM (such as choroidal neovascularization, diabetic macular edema, etc.)
Key Trial Info
Start Date :
June 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 28 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04472039
Start Date
June 30 2020
End Date
September 28 2020
Last Update
September 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
Vienna, Austria, 1140